Alphabet's Verily raises $700 million in funding round
Tweet
Share
E-mail
FILE PHOTO: A Google search page is seen through a magnifying glass in this photo illustration taken in Berlin, August 11, 2015. REUTERS/Pawel Kopczynski
(Reuters) - Alphabet Inc's life sciences division, Verily Life Sciences LLC, said it raised $700 million in a funding round from its investors including Alphabet, Silver Lake and Temasek.
The company said it would expand its commercial businesses, Baseline and Verily Health Platforms, with the funding received.
Verily, which integrates data and technology with healthcare, had also developed a COVID-19 test, which was granted an emergency use authorization by the U.S. Food and Drug Administration in September. (https://reut.rs/34pMzl8)
(Reporting by Chavi Mehta in Bengaluru; Editing by Devika Syamnath)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
- Romania adopts new measures to boost Danube waters to cool Cernavoda nuclear plant
- US Postal Service issues rules to tighten mail-in voting if court gives OK
Create E-mail Alert Related Categories
ReutersRelated Entities
Temasek Holdings, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
